Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.
Midatech is covered by the following research analysts:
Analyst: Mike Mitchell
Panmure Gordon (UK) Limited
One New Change
+44 (0)20 7886 2500
Analyst: Barry Gibb
Turner Pope Investments Limited
8 Frederick’s Place
+44 (0) 20 3657 0050
Analyst: Max Jacobs
Edison Investment Research Limited
+44 (0) 20 3077 5700
Please note that any opinions, estimates or forecasts made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Midatech or its management. Requests for copies of analyst reports should be directed at the respective analyst and institution.